Cameroon: Fight Against Aids, Tuberculosis and Malaria - An Important Conference for Cameroon

[Cameroon Tribune] President Paul Biya and wife, Chantal who arrived in Lyon yesterday, October 08, will be participating fully in the international fund raising initiative.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news

Related Links:

[Nation] The Global Fund -- the agency that helps Kenya fight HIV/Aids, tuberculosis and malaria -- has given the country Sh42 billion to be used up to 2024.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[FrontPageAfrica] Bomi County -The Liberia Coordinating Mechanism (LCM) of the Global Fund (TGF) to fight AIDS, TB and Malaria has commenced a regional consultative prioritization country dialogue to develop a joint funding request for Tuberculosis and HIV, on behalf of the country, for submission to the Fund.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[New Dawn] The Liberia Coordinating Mechanism (LCM) of the Global Fund (TGF) to fight AIDS, TB and Malaria has commenced a regional consultative prioritization country dialogue to develop a joint funding request for Tuberculosis and HIV, on behalf of the country, for submission to the Fund.
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news
Conclusion: The share of development assistance invested in the CHW projects was small, unstable and decreasing in recent years. More research is needed on tracking government investments in CHW-related projects and assessing the impact of investments on programme effectiveness. PMID: 31902960 [PubMed - in process]
Source: Bulletin of the World Health Organization - Category: International Medicine & Public Health Authors: Tags: Bull World Health Organ Source Type: research
[The Herald] Zimbabwe is assured of an adequate supply of anti-retroviral drugs (ARVs) following the allocation of US$500 million for the next three years by the Global Fund to Fight Aids, Tuberculosis and Malaria.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[Global Fund] Geneva -Following a record-breaking Replenishment in October 2019, the Global Fund today announced its largest-ever funding allocations for eligible countries to fight AIDS, tuberculosis and malaria and build systems for health over the next three years.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[The Conversation Africa] The infectious disease burden in Africa is very high, particularly for tuberculosis (TB), malaria and HIV/AIDS. In 2018, nearly a quarter (24%) of TB cases in the world were in Africa. The region accounted for 93% of malaria cases. The continent also bears the brunt of the HIV epidemic: 20.6 million of the 37.9 million people living with HIV are in eastern and southern Africa.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
[East African] The Global Fund--the body that funds developing countries to treat and prevent Aids, tuberculosis and malaria--has raised more than $14 million for the period between 2020 and 2022.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news
In conclusion, the author of this paper mentioned that immunization gap needs to be handle systematically. Immunization data released on 2017 showed that complete immunization was given only to 20% of targeted group, while almost 75% were either unvaccinated or unknown. During the outbreak of diphteria in Indonesia, the WHO also reported several countries with similar problem such as Bangladesh, Haiti and Yamen. It was shown that a coordination between doctors in clinic/hospital with public health officer to conduct an epidemiological investigation, in conjunction with giving prophylaxis and assuring the logistics of anti-...
Source: Acta medica Indonesiana - Category: Internal Medicine Tags: Acta Med Indones Source Type: research
In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to prevent tuberculosis (TB), as part of the agreement with Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official release said on Thursday.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: African Health | Cameroon Health | Conferences | HIV AIDS | Malaria | Tuberculosis